Alternatives to Alpha Tau Medical

Advancing targeted alpha therapies.

Global leader in cancer care, providing advanced technologies for radiotherapy and oncology.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Biotech company developing a novel drug delivery platform using cell membrane-derived nanoparticles.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Accelerating the development of breakthrough new medicines and medical technologies.